The PE Ratio as of December 2025 (TTM) for BioCryst Pharmaceuticals, Inc. (BCRX) is -156.60

According to BioCryst Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -156.60. This represents a change of -105.07% compared to the average of 3.09K of the last 4 quarters.

BioCryst Pharmaceuticals, Inc. (BCRX) Historical PE Ratio (quarterly & annually)

How has BCRX PE Ratio performed in the past?

The mean historical PE Ratio of BioCryst Pharmaceuticals, Inc. over the last ten years is -9.53. The current -156.60 PE Ratio has changed 164.23% with respect to the historical average. Over the past ten years (40 quarters), BCRX's PE Ratio was at its highest in in the March 2025 quarter at 12.24K. The PE Ratio was at its lowest in in the December 2019 quarter at -43.19.

BioCryst Pharmaceuticals, Inc. (BCRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BioCryst Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioCryst Pharmaceuticals, Inc. (BCRX) Average PE Ratio

How has BCRX PE Ratio performed in the past?

The current PE Ratio of BioCryst Pharmaceuticals, Inc. (BCRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BioCryst Pharmaceuticals, Inc. (BCRX) PE Ratio vs. Peers

How is BCRX’s PE Ratio compared to its peers?

BioCryst Pharmaceuticals, Inc.’s PE Ratio is less than Zymeworks Inc. (-0.10), less than Ardelyx, Inc. (-25.33), less than Maze Therapeutics, Inc. (-15.46), less than Pharvaris N.V. (-7.72), less than Spyre Therapeutics, Inc. (-77.84), less than Intellia Therapeutics, Inc. (-2.41), less than Trevi Therapeutics, Inc. (-42.62), less than Wave Life Sciences Ltd. (-10.48), less than Stoke Therapeutics, Inc. (44.86), less than Upstream Bio, Inc. (-14.28),

Build a custom stock screener for BioCryst Pharmaceuticals, Inc. (BCRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioCryst Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioCryst Pharmaceuticals, Inc. (BCRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioCryst Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.